Francesca Cottini

Hematology

410 W 10th Ave
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations.

Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations.

Journal: Cancers

Published: April 14, 2026

Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

Journal: Nature medicine

Published: February 25, 2026

Reversible cerebral vasoconstriction syndrome following ciltacabtagene autoleucel therapy for relapsed multiple myeloma: a case report.

Reversible cerebral vasoconstriction syndrome following ciltacabtagene autoleucel therapy for relapsed multiple myeloma: a case report.

Journal: Frontiers in immunology

Published: January 07, 2026

Maintenance therapy and improved relapse-free survival in patients with monoclonal gammopathy of renal significance.

Maintenance therapy and improved relapse-free survival in patients with monoclonal gammopathy of renal significance.

Journal: Blood advances

Published: October 29, 2025

Maintenance Therapy and Improved Relapse-Free Survival in Patients with Monoclonal Gammopathy of Renal Significance.

Maintenance Therapy and Improved Relapse-Free Survival in Patients with Monoclonal Gammopathy of Renal Significance.

Journal: Blood advances

Published: October 29, 2025

Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma.

Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma.

Journal: EJHaem

Published: April 15, 2025

Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.

Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.

Journal: Haematologica

Published: February 07, 2025

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

Journal: Journal of hematology & oncology

Published: December 24, 2024

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab.

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab.

Journal: Blood neoplasia

Published: November 01, 2024

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma.

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma.

Journal: Cancers

Published: June 30, 2023

Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.

Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.

Journal: Leukemia & lymphoma

Published: May 18, 2023

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma.

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma.

Journal: Frontiers in oncology

Published: May 03, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026